Marta Silva is a Molecular and Cellular Biologist, with research experience in the field of organic chemistry. After completing her bachelors degree, Marta earned a Masters in Biotechnology and she was a member of the Portuguese research institute of nano and microtechnology, INESC-MN.
Eiger BioPharmaceuticals, Inc. recently announced the filing of a new patent for a novel PAH therapy. The company’s new “Treatment of Pulmonary Hypertension with Leukotriene Inhibitors” patent is designed to cover Bestatin™ ... Read more
The Pulmonary Hypertension Association (PHA) is hosting the 2015 PH Professional Network (PHPN) Symposium, which began on Thursday, September 17 and will run until Saturday, September 19 at the Crystal ... Read more
Cellular Biomedicine, a biotechnology company developing cell-based therapies to address degenerative diseases and immunotherapies for cancer, recently announced they will present new clinical findings at the 5th World Congress on Cancer Therapy, taking place on September ... Read more
A new technique called lung filtering may offer hope for end-stage lung disease patients in need of a lung transplant. According to researchers from the University of Manchester, which is ... Read more
Pulmatrix, a biotechnology company developing new inhaled therapies to address pulmonary diseases through the company’s own clinically validated technology iSPERSE, recently announced that their lead investigational therapy for CF ... Read more
Yesterday, Proteostasis Therapeutics, Inc. (PTI) announced it had raised $37 million in new funding that will be used to develop its lead product candidate for the treatment of cystic fibrosis (CF) in ... Read more
Promedior, a biotechnology company developing targeted therapeutics to treat a range of fibrotic diseases, announced the beginning of the second phase of their PRM-151 clinical trial in patients with Idiopathic Pulmonary ... Read more